The Goldman Sachs Group Begins Coverage on Tarsus Pharmaceuticals (NASDAQ:TARS)
The Goldman Sachs Group initiated coverage on shares of Tarsus Pharmaceuticals (NASDAQ:TARS – Free Report) in a research note released on Monday, Marketbeat Ratings reports. The brokerage issued a neutral rating and a $19.00 price target on the stock. Other equities research analysts have also issued research reports about the stock. HC Wainwright upped their […]
More Stories
Top Female Superheroes that have Made History with Superpowers
Are you also one who thinks that a superhero means a powerful male or something like that? But superheroes don’t...
Bose Lifestyle Ultra Speaker Review 2026: Specification and Limitations
Looking for the best speaker in the market to upgrade your home? The Bose speaker is getting positive feedback from...
Goat Movie is Streaming on Netflix Now!
I love watching animated comedy films, but sometimes I’m unable to because they’re only available in selected regions. The Goat...
Best Music Streaming Apps in North America with Free Trials
I have spent many nights searching for the best music streaming apps. Are you also searching for the best music...
Tom Clancy’s Jack Ryan: Ghost War is Out on Amazon Prime
The popular Jack Ryan television series has a new short story in movie form. The recent release of Tom Clancy’s...
Top 10 US Industries Creating the Most Millionaires
Confused about which industry you should choose to earn fast and early money? Here, in this blog, I have mentioned...